State Street Corporation »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by State Street Corporation

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by State Street Corporation from 13F filings

Historical chart of State Street Corporation investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by State Street Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by State Street Corporation

Quarter filed Position value Share count Share price at filing
2024-06-30 $16M 15M 1.11
2024-03-31 $15M 16M 0.98
2023-12-31 $14M 15M 0.93
2023-09-30 $21M 23M 0.94

More positions owned by State Street Corporation

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Chevron Corporation (CVX)
UnitedHealth (UNH)
Tesla Motors (TSLA)

View all positions for State Street Corporation

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1